Press Releases
- Quark Pharmaceuticals Doses First Patients in Two Pivotal Phase III Studies and One Phase II Study of RNAi-Based Therapeutics for Kidney and Eye Indications
- Pershing Square Holdings, LTD. Sends Communication to Investors Regarding Valeant
- Merck Applauds the U.S. Department of Veterans Affairs (VA) for Broadening Treatment Access for Veterans with Chronic Hepatitis C Infection
- VA Expands Hepatitis C Drug Treatment
- Sight Sciences Announces the Closing of its $7MM Series B Financing Led by Hicks Equity Partners
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.

